Adrenal Support — Research Profile

The term "adrenal fatigue" is not recognized as a medical diagnosis by the Endocrine Society or mainstream endocrinology. However, HPA axis dysregulation — where chronic stress disrupts the normal cortisol rhythm — is a well-documented phenomenon with real symptoms including fatigue, poor stress tolerance, and sleep disruption. True adrenal insufficiency (Addison's disease) is a serious medical condition requiring prescription cortisol replacement and is diagnosed via ACTH stimulation testing.

Ashwagandha (KSM-66 extract, 300mg twice daily) has the strongest clinical evidence for supporting healthy cortisol levels and reducing perceived stress ^[1]. It is backed by multiple RCTs and a meta-analysis. Rhodiola rosea (200-400mg SHR-5 extract) is a strong second choice, particularly for stress-related fatigue and mental performance. For best results, ensure adequate vitamin C, B-complex, and magnesium intake alongside adaptogens.

Most adaptogens require 4-8 weeks of consistent daily use to show measurable benefits. Some people notice improved energy and stress resilience within 1-2 weeks, while cortisol normalization and HPA axis recalibration may take 2-3 months. Lifestyle factors — sleep, stress management, balanced nutrition — are equally important and should accompany supplementation for optimal results.

No single "best form" exists because the category covers distinct ingredients with different evidence. The best-supported options are standardized ashwagandha root extract and Rhodiola rosea extract, both trialed as capsules or tablets; a phosphatidylserine/phosphatidic acid complex has also blunted stress-related cortisol in one dose-finding study. By contrast, "adrenal glandular" tissue products have no controlled trial evidence behind them.

The strongest evidence is for specific adaptogens, not for repairing an "adrenal" problem. In stressed but healthy adults, standardized ashwagandha (240 mg/day for 60 days) significantly reduced morning cortisol (P <.001) and anxiety scores, and Rhodiola rosea (576 mg/day for 28 days) improved fatigue and the cortisol awakening response in people with fatigue syndrome. Notably, a systematic review concluded that "adrenal fatigue" is not a real medical condition, so these products relieve stress and fatigue symptoms rather than fixing a depleted adrenal gland.

There is no single daily dose because the label covers multiple ingredients; use the amount studied for each active. Trials used 240 mg/day of Shoden ashwagandha extract, 576 mg/day of SHR-5 Rhodiola rosea, and 400 mg/day of a phosphatidylserine complex - and notably the phosphatidylserine effect on cortisol appeared at 400 mg but not at higher 600-800 mg doses. Match the per-ingredient clinical dose rather than a blend's total milligram count.

Timing depends on the ingredient and goal, and head-to-head timing comparisons have not been done. Ashwagandha's benefit was measured on morning cortisol and it can cause drowsiness (NCCIH), so it is often taken in the evening; Rhodiola is usually taken earlier in the day because it is used for fatigue and mental performance. In its cortisol study, the phosphatidylserine complex was dosed ahead of an acute stress test.

Side effects depend on the specific ingredient in the formula. Per NCCIH, ashwagandha can cause drowsiness, stomach upset, diarrhea, and vomiting, with rare reports of liver injury. If the product contains licorice, NCCIH notes glycyrrhizin can cause irregular heartbeat in large or long-term amounts, and Memorial Sloan Kettering adds that it can raise blood pressure and lower blood potassium. Rhodiola is used for fatigue and can feel mildly stimulating, so it may be better avoided late in the day.

Yes - several common ingredients interact with medications. NCCIH notes ashwagandha may interact with diabetes and blood-pressure drugs, immunosuppressants, sedatives, anticonvulsants, and thyroid hormone medication, and it may worsen thyroid or autoimmune conditions. For licorice, Memorial Sloan Kettering reports interactions with corticosteroids and cardiac (heart-failure and antiarrhythmic) drugs, and because licorice lowers blood potassium it adds risk for people taking potassium-depleting diuretics.

These products are marketed for stress, fatigue, and "burnout," and the adaptogen evidence comes from stressed-but-healthy adults or people with fatigue syndrome. They are not a treatment for diagnosed adrenal disease such as Addison's or Cushing's, and because a systematic review concluded "adrenal fatigue" is not a recognized diagnosis, persistent unexplained exhaustion should be medically evaluated rather than self-treated. NCCIH also advises avoiding ashwagandha in pregnancy and breastfeeding and in people with thyroid or autoimmune disorders or upcoming surgery.

"Adrenal Support" is a category label rather than a single compound, so onset depends on which active it contains. In trials, standardized ashwagandha extract (240 mg/day) lowered morning cortisol and anxiety scores over 60 days, Rhodiola rosea extract (576 mg/day) improved fatigue over 28 days, and a phosphatidylserine complex blunted stress-induced cortisol after about 3 weeks. Expect a few weeks of daily use rather than same-day effects; none of these acts meaningfully from a single dose.

Long-term safety has not been established for most adrenal-support ingredients. NCCIH considers ashwagandha possibly safe only in the short term (up to 3 months) and notes rare reports of ashwagandha-linked liver injury. Formulas that include licorice are riskier for continuous use: NCCIH warns that glycyrrhizin can cause irregular heartbeat, and even cardiac arrest, with large or long-term intake, and Memorial Sloan Kettering's herb monograph notes licorice can raise blood pressure and lower blood potassium, so licorice-containing products in particular should not be taken indefinitely.

There is no defined upper limit because the category spans many different ingredients, but overdoing it is possible. Per NCCIH, high ashwagandha intake can cause stomach upset, diarrhea, drowsiness, and vomiting, with rare liver injury. Licorice is the clearest overdose hazard: NCCIH states even small amounts of glycyrrhizin have been linked to severe effects in people with hypertension or heart or kidney conditions, and Memorial Sloan Kettering documents that licorice can drive blood potassium dangerously low (pseudohyperaldosteronism).

These products already stack several actives (commonly ashwagandha, Rhodiola, phosphatidylserine, and B vitamins), so adding more cortisol-lowering or sedating supplements risks unwanted overlap, and combining multiple adaptogens has not been shown to add benefit in controlled trials. Because ashwagandha can cause drowsiness (NCCIH), keep it separate from other sedating products. If the formula contains licorice, avoid pairing it with anything else that lowers potassium, since Memorial Sloan Kettering notes licorice itself lowers blood potassium.

Favor a product that names a standardized, studied extract instead of a vague "adrenal blend" - for example Shoden ashwagandha at 240 mg/day or SHR-5 Rhodiola rosea at 576 mg/day, the amounts used in trials. Be skeptical of formulas built around raw adrenal-gland (glandular) tissue, which has no controlled clinical support, and check whether licorice is present, since Memorial Sloan Kettering notes it can raise blood pressure and lower blood potassium. Third-party testing (USP or NSF) helps confirm the label matches the contents.